Bhubaneswar Among Trial Sites For India’s First Nasal COVID-19 Vaccine
New Delhi: Indian vaccine maker Bharat Biotech is all set to start phase 1 and 2 trials of a nasal vaccine for COVID-19 at Gillurkar Multi Speciality in Nagpur.
“We are working on a nasal vaccine and have partnered with the Washington…